| 1TVO | A: | THE STRUCTURE OF ERK2 IN COMPLEX WITH A SMALL MOLECULE INHIBITOR |
| 1W7H | A: | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR |
| 1W82 | A: | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR |
| 1W83 | A: | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR |
| 1W84 | A: | P38 KINASE CRYSTAL STRUCTURE IN COMPLEX WITH SMALL MOLECULE INHIBITOR |
| 1WBN | A: | FRAGMENT BASED P38 INHIBITORS |
| 1WBO | A: | FRAGMENT BASED P38 INHIBITORS |
| 1WBS | A: | IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION. |
| 1WBT | A: | IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION. |
| 1WBV | A: | IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION. |
| 1WBW | A: | IDENTIFICATION OF NOVEL P38 ALPHA MAP KINASE INHIBITORS USING FRAGMENT-BASED LEAD GENERATION. |
| 1WVW | A: | CRYSTAL STRUCTURES OF KINASE DOMAIN OF DAP KINASE IN COMPLEX WITH SMALL MOLECULAR INHIBITORS |
| 1WVX | A: | CRYSTAL STRUCTURES OF KINASE DOMAIN OF DAP KINASE IN COMPLEX WITH SMALL MOLECULAR INHIBITORS |
| 1WVY | A: | CRYSTAL STRUCTURES OF KINASE DOMAIN OF DAP KINASE IN COMPLEX WITH SMALL MOLECULAR INHIBITORS |
| 1WZY | A: | CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A PYRAZOLOPYRIDAZINE DERIVATIVE |
| 1ZWS | A:; B:; C:; D:; E:; F:; G:; H: | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN DRP-1 KINASE |
| 2A27 | A:; B:; C:; D:; E:; F:; G:; H: | HUMAN DRP-1 KINASE, W305S S308A D40 MUTANT, CRYSTAL FORM WITH 8 MONOMERS IN THE ASYMMETRIC UNIT |
| 2BIY | A: | STRUCTURE OF PDK1-S241A MUTANT KINASE DOMAIN |
| 2BKZ | A:; C: | STRUCTURE OF CDK2-CYCLIN A WITH PHA-404611 |
| 2BPM | A:; C: | STRUCTURE OF CDK2-CYCLIN A WITH PHA-630529 |
| 2BR1 | A: | STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY |
| 2BRB | A: | STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY |
| 2BRG | A: | STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY |
| 2BRH | A: | STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY |
| 2BRM | A: | STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY |
| 2BRN | A: | STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY |
| 2BRO | A: | STRUCTURE-BASED DESIGN OF NOVEL CHK1 INHIBITORS: INSIGHTS INTO HYDROGEN BONDING AND PROTEIN-LIGAND AFFINITY |
| 2C3J | A: | IDENTIFICATION OF A BURIED POCKET FOR POTENT AND SELECTIVE INHIBITION OF CHK1: PREDICTION AND VERIFICATION |
| 2C3K | A: | IDENTIFICATION OF A BURIED POCKET FOR POTENT AND SELECTIVE INHIBITION OF CHK1: PREDICTION AND VERIFICATION |
| 2C3L | A: | IDENTIFICATION OF A BURIED POCKET FOR POTENT AND SELECTIVE INHIBITION OF CHK1: PREDICTION AND VERIFICATION |
| 2C47 | A:; B:; C:; D: | STRUCTURE OF CASEIN KINASE 1 GAMMA 2 |
| 2C4G | A:; C: | STRUCTURE OF CDK2-CYCLIN A WITH PHA-533514 |
| 2C6D | A: | AURORA A KINASE ACTIVATED MUTANT (T287D) IN COMPLEX WITH ADPNP |
| 2C6E | A:; B: | AURORA A KINASE ACTIVATED MUTANT (T287D) IN COMPLEX WITH A 5-AMINOPYRIMIDINYL QUINAZOLINE INHIBITOR |
| 2CGU | A: | IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING |
| 2CGV | A: | IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING |
| 2CGW | A: | IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING |
| 2CGX | A: | IDENTIFICATION OF CHEMICALLY DIVERSE CHK1 INHIBITORS BY RECEPTOR-BASED VIRTUAL SCREENING |
| 2CHL | A: | STRUCTURE OF CASEIN KINASE 1 GAMMA 3 |
| 2CMW | A: | STRUCTURE OF HUMAN CASEIN KINASE 1 GAMMA-1 IN COMPLEX WITH 2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE (CASP TARGET) |
| 2DWB | A: | AURORA-A KINASE COMPLEXED WITH AMPPNP |
| 2E2B | A:; B: | CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH INNO-406 |
| 2E9N | A: | STRUCTURE OF H-CHK1 COMPLEXED WITH A767085 |
| 2E9O | A: | STRUCTURE OF H-CHK1 COMPLEXED WITH AA582939 |
| 2E9P | A: | STRUCTURE OF H-CHK1 COMPLEXED WITH A771129 |
| 2E9U | A: | STRUCTURE OF H-CHK1 COMPLEXED WITH A780125 |
| 2E9V | A:; B: | STRUCTURE OF H-CHK1 COMPLEXED WITH A859017 |
| 2F4J | A: | STRUCTURE OF THE KINASE DOMAIN OF AN IMATINIB-RESISTANT ABL MUTANT IN COMPLEX WITH THE AURORA KINASE INHIBITOR VX-680 |
| 2FB8 | A:; B: | STRUCTURE OF THE B-RAF KINASE DOMAIN BOUND TO SB-590885 |
| 2FSL | X: | MITOGEN ACTIVATED PROTEIN KINASE P38ALPHA (D176A+F327S) ACTIVATING MUTANT FORM-A |
| 2FSM | X: | MITOGEN ACTIVATED PROTEIN KINASE P38ALPHA (D176A+F327S) ACTIVATING MUTANT FORM-B |
| 2FSO | X: | MITOGEN ACTIVATED PROTEIN KINASE P38ALPHA (D176A) ACTIVATING MUTANT |
| 2FST | X: | MITOGEN ACTIVATED PROTEIN KINASE P38ALPHA (D176A+F327L) ACTIVATING MUTANT |
| 2G15 | A: | STRUCTURAL CHARACTERIZATION OF AUTOINHIBITED C-MET KINASE |
| 2G2H | A:; B: | A SRC-LIKE INACTIVE CONFORMATION IN THE ABL TYROSINE KINASE DOMAIN |
| 2GDO | A: | 4-(AMINOALKYLAMINO)-3-BENZIMIDAZOLE-QUINOLINONES AS POTENT CHK1 INHIBITORS |
| 2GQG | A:; B: | X-RAY CRYSTAL STRUCTURE OF DASATINIB (BMS-354825) BOUND TO ACTIVATED ABL KINASE DOMAIN |
| 2GU8 | A: | DISCOVERY OF 2-PYRIMIDYL-5-AMIDOTHIOPHENES AS NOVEL AND POTENT INHIBITORS FOR AKT: SYNTHESIS AND SAR STUDIES |
| 2HIW | A:; B: | CRYSTAL STRUCTURE OF INACTIVE CONFORMATION ABL KINASE CATALYTIC DOMAIN COMPLEXED WITH TYPE II INHIBITOR |
| 2HXL | A: | CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 1 |
| 2HXQ | A: | CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 2 |
| 2HY0 | A: | CRYSTAL STRUCTURE OF CHEK1 IN COMPLEX WITH INHIBITOR 22 |
| 2I0E | A:; B: | STRUCTURE OF CATALYTIC DOMAIN OF HUMAN PROTEIN KINASE C BETA II COMPLEXED WITH A BISINDOLYLMALEIMIDE INHIBITOR |
| 2I0V | A: | C-FMS TYROSINE KINASE IN COMPLEX WITH A QUINOLONE INHIBITOR |
| 2I0Y | A: | CFMS TYROSINE KINASE (FGF KID) IN COMPLEX WITH AN ARYLAMIDE INHIBITOR |
| 2I1M | A: | CFMS TYROSINE KINASE (TIE2 KID) IN COMPLEX WITH AN ARYLAMIDE INHIBITOR |
| 2ITN | A: | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN G719S MUTATION IN COMPLEX WITH AMP-PNP |
| 2ITP | A: | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN G719S MUTATION IN COMPLEX WITH AEE788 |
| 2ITQ | A: | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN G719S MUTATION IN COMPLEX WITH AFN941 |
| 2ITT | A: | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH AEE788 |
| 2ITU | A: | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH AFN941 |
| 2ITV | A: | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH AMP-PNP |
| 2ITW | A: | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AFN941 |
| 2ITX | A: | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AMP-PNP |
| 2ITZ | A: | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH IRESSA |
| 2IW8 | C: | STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR |
| 2IZR | A: | STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR |
| 2IZS | A: | STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR |
| 2IZT | A: | STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR |
| 2IZU | A: | STRUCTURE OF CASEIN KINASE GAMMA 3 IN COMPLEX WITH INHIBITOR |
| 2J5E | A: | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AN IRREVERSIBLE INHIBITOR 13-JAB |
| 2J5F | A: | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AN IRREVERSIBLE INHIBITOR 34-JAB |
| 2J6M | A: | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AEE788 |
| 2J7T | A: | CRYSTAL STRUCTURE OF HUMAN SERINE THREONINE KINASE-10 BOUND TO SU11274 |
| 2J90 | A:; B: | CRYSTAL STRUCTURE OF HUMAN ZIP KINASE IN COMPLEX WITH A TETRACYCLIC PYRIDONE INHIBITOR (PYRIDONE 6) |
| 2JAM | A:; B: | CRYSTAL STRUCTURE OF HUMAN CALMODULIN-DEPENDENT PROTEIN KINASE I G |
| 2JBO | A: | PROTEIN KINASE MK2 IN COMPLEX WITH AN INHIBITOR (CRYSTAL FORM-1, SOAKING) |
| 2JC6 | A:; C: | CRYSTAL STRUCTURE OF HUMAN CALMODULIN-DEPENDENT PROTEIN KINASE 1D |
| 2JED | A:; B: | THE CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF THE PROTEIN KINASE C THETA IN COMPLEX WITH NVP-XAA228 AT 2.32A RESOLUTION. |
| 2JIT | A:; B: | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION |
| 2JIU | A:; B: | CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION IN COMPLEX WITH AEE788 |
| 2NP8 | A: | STRUCTURAL BASIS FOR THE INHIBITION OF AURORA A KINASE BY A NOVEL CLASS OF HIGH AFFINITY DISUBSTITUTED PYRIMIDINE INHIBITORS |
| 2NPQ | A: | A NOVEL LIPID BINDING SITE IN THE P38 ALPHA MAP KINASE |
| 2OBJ | A: | CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH INHIBITOR |
| 2OGV | A: | CRYSTAL STRUCTURE OF THE AUTOINHIBITED HUMAN C-FMS KINASE DOMAIN |
| 2OJG | A: | CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE |
| 2OJI | A: | CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH N-BENZYL-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE |
| 2OJJ | A: | CRYSTAL STRUCTURE OF ERK2 IN COMPLEX WITH (S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE |
| 2OO8 | X: | SYNTHESIS, STRUCTURAL ANALYSIS, AND SAR STUDIES OF TRIAZINE DERIVATIVES AS POTENT, SELECTIVE TIE-2 INHIBITORS |
| 2OSC | A: | SYNTHESIS, STRUCTURAL ANALYSIS, AND SAR STUDIES OF TRIAZINE DERIVATIVES AS POTENT, SELECTIVE TIE-2 INHIBITORS |
| 2P4I | A:; B: | EVOLUTION OF A HIGHLY SELECTIVE AND POTENT 2-(PYRIDIN-2-YL)-1,3,5-TRIAZINE TIE-2 KINASE INHIBITOR |
| 2R2P | A: | KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 5 (EPHA5) |
| 2REI | A: | KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 7 (EPHA7) |
| 2V7A | A:; B: | CRYSTAL STRUCTURE OF THE T315I ABL MUTANT IN COMPLEX WITH THE INHIBITOR PHA-739358 |
| 2W1D | A: | STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR |
| 2W1E | A: | STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR |
| 2W1F | A: | STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR |
| 2W1G | A: | STRUCTURE DETERMINATION OF AURORA KINASE IN COMPLEX WITH INHIBITOR |
| 2W4J | A: | X-RAY STRUCTURE OF A DAP-KINASE 2-277 |
| 2W4K | A: | X-RAY STRUCTURE OF A DAP-KINASE 2-302 |
| 2W5A | A: | HUMAN NEK2 KINASE ADP-BOUND |
| 2W5B | A: | HUMAN NEK2 KINASE ATPGAMMAS-BOUND |
| 2W5H | A: | HUMAN NEK2 KINASE APO |
| 2W96 | B: | CRYSTAL STRUCTURE OF CDK4 IN COMPLEX WITH A D-TYPE CYCLIN |
| 2W99 | B: | CRYSTAL STRUCTURE OF CDK4 IN COMPLEX WITH A D-TYPE CYCLIN |
| 2W9F | B: | CRYSTAL STRUCTURE OF CDK4 IN COMPLEX WITH A D-TYPE CYCLIN |
| 2W9Z | B: | CRYSTAL STRUCTURE OF CDK4 IN COMPLEX WITH A D-TYPE CYCLIN |
| 2WAJ | A: | CRYSTAL STRUCTURE OF HUMAN JNK3 COMPLEXED WITH A 1-ARYL-3,4-DIHYDROISOQUINOLINE INHIBITOR |
| 2WGJ | A: | X-RAY STRUCTURE OF PF-02341066 BOUND TO THE KINASE DOMAIN OF C-MET |
| 2WIH | A:; C: | STRUCTURE OF CDK2-CYCLIN A WITH PHA-848125 |
| 2WIP | A:; C: | STRUCTURE OF CDK2-CYCLIN A COMPLEXED WITH 8-ANILINO-1-METHYL-4,5-DIHYDRO-1H-PYRAZOLO[4,3-H] QUINAZOLINE-3-CARBOXYLIC ACID |
| 2WKM | A: | X-RAY STRUCTURE OF PHA-00665752 BOUND TO THE KINASE DOMAIN OF C-MET |
| 2WMQ | A: | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS |
| 2WMR | A: | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS |
| 2WMS | A: | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS |
| 2WMT | A: | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS |
| 2WMU | A: | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS |
| 2WMV | A: | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS |
| 2WMW | A: | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS |
| 2WMX | A: | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS |
| 2WPA | A:; C: | OPTIMISATION OF 6,6-DIMETHYL PYRROLO 3,4-C PYRAZOLES: IDENTIFICATION OF PHA-793887, A POTENT CDK INHIBITOR SUITABLE FOR INTRAVENOUS DOSING |
| 2WQB | A: | STRUCTURE OF THE TIE2 KINASE DOMAIN IN COMPLEX WITH A THIAZOLOPYRIMIDINE INHIBITOR |
| 2WQO | A: | STRUCTURE OF NEK2 BOUND TO THE AMINOPYRIDINE CCT241950 |
| 2WTV | A:; B:; C:; D: | AURORA-A INHIBITOR STRUCTURE |
| 2WXV | A:; C: | STRUCTURE OF CDK2-CYCLIN A WITH A PYRAZOLO(4,3-H) QUINAZOLINE-3-CARBOXAMIDE INHIBITOR |
| 2X0G | A: | X-RAY STRUCTURE OF A DAP-KINASE CALMODULIN COMPLEX |
| 2X6D | A: | AURORA-A BOUND TO AN INHIBITOR |
| 2X81 | A: | STRUCTURE OF AURORA A IN COMPLEX WITH MLN8054 |
| 2X8D | A: | DISCOVERY OF A NOVEL CLASS OF TRIAZOLONES AS CHECKPOINT KINASE INHIBITORS - HIT TO LEAD EXPLORATION |
| 2X8I | A: | DISCOVERY OF A NOVEL CLASS OF TRIAZOLONES AS CHECKPOINT KINASE INHIBITORS - HIT TO LEAD EXPLORATION |
| 2XCH | A: | CRYSTAL STRUCTURE OF PDK1 IN COMPLEX WITH A PYRAZOLOQUINAZOLINE INHIBITOR |
| 2XCK | A: | CRYSTAL STRUCTURE OF PDK1 IN COMPLEX WITH A PYRAZOLOQUINAZOLINE INHIBITOR |
| 2XEY | A: | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS |
| 2XEZ | A: | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS |
| 2XF0 | A: | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS |
| 2XIX | A: | PROTEIN KINASE PIM-1 IN COMPLEX WITH FRAGMENT-1 FROM CRYSTALLOGRAPHIC FRAGMENT SCREEN |
| 2XIY | A: | PROTEIN KINASE PIM-1 IN COMPLEX WITH FRAGMENT-2 FROM CRYSTALLOGRAPHIC FRAGMENT SCREEN |
| 2XIZ | A: | PROTEIN KINASE PIM-1 IN COMPLEX WITH FRAGMENT-3 FROM CRYSTALLOGRAPHIC FRAGMENT SCREEN |
| 2XJ0 | A: | PROTEIN KINASE PIM-1 IN COMPLEX WITH FRAGMENT-4 FROM CRYSTALLOGRAPHIC FRAGMENT SCREEN |
| 2XJ1 | A: | PROTEIN KINASE PIM-1 IN COMPLEX WITH SMALL MOLECULE INIBITOR |
| 2XK3 | A: | STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 35 |
| 2XK4 | A: | STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 17 |
| 2XK6 | A: | STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 36 |
| 2XK7 | A: | STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 23 |
| 2XK8 | A: | STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 15 |
| 2XKC | A: | STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 14 |
| 2XKD | A: | STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 12 |
| 2XKE | A: | STRUCTURE OF NEK2 BOUND TO AMINIPYRAZINE COMPOUND 5 |
| 2XKF | A: | STRUCTURE OF NEK2 BOUND TO AMINOPYRAZINE COMPOUND 2 |
| 2XNE | A: | STRUCTURE OF AURORA-A BOUND TO AN IMIDAZOPYRAZINE INHIBITOR |
| 2XNG | A: | STRUCTURE OF AURORA-A BOUND TO A SELECTIVE IMIDAZOPYRAZINE INHIBITOR |
| 2XNM | A: | STRUCTURE OF NEK2 BOUND TO CCT |
| 2XNN | A: | STRUCTURE OF NEK2 BOUND TO CCT242430 |
| 2XNO | A: | STRUCTURE OF NEK2 BOUND TO CCT243779 |
| 2XNP | A: | STRUCTURE OF NEK2 BOUND TO CCT244858 |
| 2XRU | A: | AURORA-A T288E COMPLEXED WITH PHA-828300 |
| 2XRW | A: | LINEAR BINDING MOTIFS FOR JNK AND FOR CALCINEURIN ANTAGONISTICALLY CONTROL THE NUCLEAR SHUTTLING OF NFAT4 |
| 2XUU | A: | CRYSTAL STRUCTURE OF A DAP-KINASE 1 MUTANT |
| 2XYN | A:; B:; C: | HUMAN ABL2 IN COMPLEX WITH AURORA KINASE INHIBITOR VX-680 |
| 2XZS | A:; B: | DEATH ASSOCIATED PROTEIN KINASE 1 RESIDUES 1-312 |
| 2Y0A | A: | STRUCTURE OF DAPK1 CONSTRUCT RESIDUES 1-304 |
| 2Y4P | A:; B:; C:; D: | DIMERIC STRUCTURE OF DAPK-1 CATALYTIC DOMAIN |
| 2YAK | A: | STRUCTURE OF DEATH-ASSOCIATED PROTEIN KINASE 1 (DAPK1) IN COMPLEX WITH A RUTHENIUM OCTASPORINE LIGAND (OSV) |
| 2YDI | A: | DISCOVERY OF CHECKPOINT KINASE INHIBITOR AZD7762 BY STRUCTURE BASED DESIGN AND OPTIMIZATION OF THIOPHENE CARBOXAMIDE UREAS |
| 2YDK | A: | DISCOVERY OF CHECKPOINT KINASE INHIBITOR AZD7762 BY STRUCTURE BASED DESIGN AND OPTIMIZATION OF THIOPHENE CARBOXAMIDE UREAS |
| 2YER | A: | SYNTHESIS AND EVALUATION OF TRIAZOLONES AS CHECKPOINT KINASE 1 INHIBITORS |
| 2YEX | A: | SYNTHESIS AND EVALUATION OF TRIAZOLONES AS CHECKPOINT KINASE 1 INHIBITORS |
| 2YIS | A: | TRIAZOLOPYRIDINE INHIBITORS OF P38 KINASE. |
| 2YIW | A: | TRIAZOLOPYRIDINE INHIBITORS OF P38 KINASE |
| 2YIX | A: | TRIAZOLOPYRIDINE INHIBITORS OF P38 |
| 2YM3 | A: | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS |
| 2YM4 | A: | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS |
| 2YM5 | A: | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS |
| 2YM6 | A: | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS |
| 2YM7 | A: | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS |
| 2YM8 | A: | CRYSTAL STRUCTURE OF CHECKPOINT KINASE 1 (CHK1) IN COMPLEX WITH INHIBITORS |
| 2ZAZ | A: | CRYSTAL STRUCTURE OF P38 IN COMPLEX WITH 4-ANILINO QUINOLINE INHIBITOR |
| 2ZB0 | A: | CRYSTAL STRUCTURE OF P38 IN COMPLEX WITH BIPHENYL AMIDE INHIBITOR |
| 2ZB1 | A: | CRYSTAL STRUCTURE OF P38 IN COMPLEX WITH BIPHENYL AMIDE INHIBITOR |
| 2ZDT | A: | CRYSTAL STRUCTURE OF HUMAN JNK3 COMPLEXED WITH AN ISOQUINOLONE INHIBITOR |
| 2ZDU | A: | CRYSTAL STRUCTURE OF HUMAN JNK3 COMPLEXED WITH AN ISOQUINOLONE INHIBITOR |
| 2ZJW | A: | CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA COMPLEXED WITH ELLAGIC ACID |
| 2ZOQ | A:; B: | STRUCTURAL DISSECTION OF HUMAN MITOGEN-ACTIVATED KINASE ERK1 |
| 3A2C | A:; B:; C:; D:; E:; F:; G:; H:; I:; J:; K:; L: | CRYSTAL STRUCTURE OF A PYRAZOLOPYRIMIDINE INHIBITOR COMPLEX BOUND TO MAPKAP KINASE-2 (MK2) |
| 3A4P | A: | HUMAN C-MET KINASE DOMAIN COMPLEXED WITH 6-BENZYLOXYQUINOLINE INHIBITOR |
| 3AGL | A:; B: | COMPLEX OF PKA WITH THE BISUBSTRATE PROTEIN KINASE INHIBITOR ARC-1039 |
| 3AGM | A: | COMPLEX OF PKA WITH THE BISUBSTRATE PROTEIN KINASE INHIBITOR ARC-670 |
| 3AMY | A: | CRYSTAL STRUCTURE OF HUMAN CK2 ALPHA COMPLEXED WITH APIGENIN |
| 3AXW | A: | CRYSTAL STRUCTURE OF HUMAN CK2ALPHA COMPLEXED WITH A POTENT INHIBITOR |
| 3B2T | A:; B: | STRUCTURE OF PHOSPHOTRANSFERASE |
| 3BBT | B:; D: | CRYSTAL STRUCTURE OF THE ERBB4 KINASE IN COMPLEX WITH LAPATINIB |
| 3BCE | A:; B:; C: | CRYSTAL STRUCTURE OF THE ERBB4 KINASE |
| 3BEA | A: | CFMS TYROSINE KINASE (TIE2 KID) IN COMPLEX WITH A PYRIMIDINOPYRIDONE INHIBITOR |
| 3CC6 | A: | CRYSTAL STRUCTURE OF KINASE DOMAIN OF PROTEIN TYROSINE KINASE 2 BETA (PTK2B) |
| 3CIK | A:186-549 | HUMAN GRK2 IN COMPLEX WITH GBETAGAMMA SUBUNITS |
| 3CLY | A: | CRYSTAL STRUCTURE OF FGF RECEPTOR 2 (FGFR2) KINASE DOMAINS TRAPPED IN TRANS-PHOSPHORYLATION REACTION |
| 3COI | A: | CRYSTAL STRUCTURE OF P38DELTA KINASE |
| 3CQU | A: | CRYSTAL STRUCTURE OF AKT-1 COMPLEXED WITH SUBSTRATE PEPTIDE AND INHIBITOR |
| 3CQW | A: | CRYSTAL STRUCTURE OF AKT-1 COMPLEXED WITH SUBSTRATE PEPTIDE AND INHIBITOR |
| 3CS9 | A:; B:; C:; D: | HUMAN ABL KINASE IN COMPLEX WITH NILOTINIB |
| 3D4Q | A:; B: | PYRAZOLE-BASED INHIBITORS OF B-RAF KINASE |
| 3DFC | B: | CRYSTAL STRUCTURE OF A GLYCINE-RICH LOOP MUTANT OF THE DEATH ASSOCIATED PROTEIN KINASE CATALYTIC DOMAIN WITH AMPPNP |
| 3DGK | A: | CRYSTAL STRUCTURE OF A GLYCINE-RICH LOOP MUTANT OF THE DEATH ASSOCIATED PROTEIN KINASE CATALYTIC DOMAIN |
| 3DKO | A: | COMPLEX BETWEEN THE KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 7 (EPHA7) AND INHIBITOR ALW-II-49-7 |
| 3DPK | A: | CFMS TYROSINE KINASE IN COMPLEX WITH A PYRIDOPYRIMIDINONE INHIBITOR |
| 3E7O | A:; B: | CRYSTAL STRUCTURE OF JNK2 |
| 3E92 | A: | CRYSTAL STRUCTURE OF P38 KINASE IN COMPLEX WITH A BIARYL AMIDE INHIBITOR |
| 3E93 | A: | CRYSTAL STRUCTURE OF P38 KINASE IN COMPLEX WITH A BIARYL AMIDE INHIBITOR |
| 3EH9 | A: | CRYSTAL STRUCTURE OF DEATH ASSOCIATED PROTEIN KINASE COMPLEXED WITH ADP |
| 3EHA | A: | CRYSTAL STRUCTURE OF DEATH ASSOCIATED PROTEIN KINASE COMPLEXED WITH AMPPNP |
| 3ELJ | A: | JNK1 COMPLEXED WITH A BIS-ANILINO-PYRROLOPYRIMIDINE INHIBITOR. |
| 3ET7 | A: | CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH PF-2318841 |
| 3F5G | A: | CRYSTAL STRUCTURE OF DEATH ASSOCIATED PROTEIN KINASE IN COMPLEX WITH ADP AND MG2+ |
| 3F5U | A: | CRYSTAL STRUCTURE OF THE DEATH ASSOCIATED PROTEIN KINASE IN COMPLEX WITH AMPPNP AND MG2+ |
| 3FDN | A: | STRUCTURE-BASED DRUG DESIGN OF NOVEL AURORA KINASE A INHIBITORS: STRUCTURE BASIS FOR POTENCY AND SPECIFICITY |
| 3FHR | A: | HIGH RESOLUTION CRYSTAL STRUCTURE OF MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 3 (MK3)-INHIBITOR COMPLEX |
| 3FWQ | A:; B: | INACTIVE CONFORMATION OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT |
| 3FXW | A: | HIGH RESOLUTION CRYSTAL STRUCTURE OF MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 3/INHIBITOR 2 COMPLEX |
| 3FZO | A: | CRYSTAL STRUCTURE OF PYK2-APO, PROLINE-RICH TYROSINE KINASE |
| 3FZP | A: | CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH ATPGS |
| 3FZR | A: | CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH PF-431396 |
| 3FZS | A: | CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH BIRB796 |
| 3FZT | A: | CRYSTAL STRUCTURE OF PYK2 COMPLEXED WITH PF-4618433 |
| 3G33 | A:; C: | CRYSTAL STRUCTURE OF CDK4/CYCLIN D3 |
| 3GB2 | A: | GSK3BETA INHIBITOR COMPLEX |
| 3GC7 | A: | THE STRUCTURE OF P38ALPHA IN COMPLEX WITH A DIHYDROQUINAZOLINONE |
| 3GC8 | A:; B: | THE STRUCTURE OF P38BETA C162S IN COMPLEX WITH A DIHYDROQUINAZOLINONE |
| 3GC9 | A:; B: | THE STRUCTURE OF P38BETA C119S, C162S IN COMPLEX WITH A DIHYDROQUINAZOLINONE INHIBITOR |
| 3GEN | A: | THE 1.6 A CRYSTAL STRUCTURE OF HUMAN BRUTON'S TYROSINE KINASE BOUND TO A PYRROLOPYRIMIDINE-CONTAINING COMPOUND |
| 3GP0 | A: | CRYSTAL STRUCTURE OF HUMAN MITOGEN ACTIVATED PROTEIN KINASE 11 (P38 BETA) IN COMPLEX WITH NILOTINIB |
| 3GQI | A: | CRYSTAL STRUCTURE OF ACTIVATED RECEPTOR TYROSINE KINASE IN COMPLEX WITH SUBSTRATES |
| 3GQL | A:; B:; C: | CRYSTAL STRUCTURE OF ACTIVATED RECEPTOR TYROSINE KINASE IN COMPLEX WITH SUBSTRATES |
| 3GU4 | A: | CRYSTAL STRUCTURE OF DAPKQ23V-AMPPNP |
| 3GU5 | A: | CRYSTAL STRUCTURE OF DAPKQ23V-AMPPNP-MG2+ |
| 3GU6 | A: | CRYSTAL STRUCTURE OF DAPKQ23V-ADP |
| 3GU7 | A: | CRYSTAL STRUCTURE OF DAPKQ23V-ADP-MG2+ |
| 3GU8 | A: | CRYSTAL STRUCTURE OF DAPKL93G WITH N6-CYCLOPENTYLADENOSINE |
| 3GUB | A: | CRYSTAL STRUCTURE OF DAPKL93G COMPLEXED WITH N6-(2-PHENYLETHYL)ADENOSINE |
| 3GVU | A: | THE CRYSTAL STRUCTURE OF HUMAN ABL2 IN COMPLEX WITH GLEEVEC |
| 3H3C | A: | CRYSTAL STRUCTURE OF PYK2 IN COMPLEX WITH SULFOXIMINE-SUBSTITUTED TRIFLUOROMETHYLPYRIMIDINE ANALOG |
| 3H9R | A: | CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF TYPE I ACTIVIN RECEPTOR (ACVR1) IN COMPLEX WITH FKBP12 AND DORSOMORPHIN |
| 3HA6 | A: | CRYSTAL STRUCTURE OF AURORA A IN COMPLEX WITH TPX2 AND COMPOUND 10 |
| 3HL7 | A: | CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH SD-0006 |
| 3HLL | A: | CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH PH-797804 |
| 3HMI | A: | THE CRYSTAL STRUCTURE OF HUMAN ABL2 IN COMPLEX WITH 5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE |
| 3HP2 | A: | CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH A PYRIDINONE COMPOUND |
| 3HP5 | A: | CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH A PYRIMIDOPYRIDAZINONE COMPOUND |
| 3I5Z | A: | CRYSTAL STRUCTURE OF ERK2 BOUND TO (S)-N-(2-HYDROXY-1-PHENYLETHYL)-4-(5-METHYL-2-(PHENYLAMINO)PYRIMIDIN-4-YL)-1H-PYRROLE-2-CARBOXAMIDE |
| 3I60 | A: | CRYSTAL STRUCTURE OF ERK2 BOUND TO (S)-4-(2-(2-CHLOROPHENYLAMINO)-5-METHYLPYRIMIDIN-4-YL)-N-(2-HYDROXY-1-PHENYLETHYL)-1H-PYRROLE-2-CARBOXAMIDE |
| 3IDP | A:; B: | B-RAF V600E KINASE DOMAIN IN COMPLEX WITH AN AMINOISOQUINOLINE INHIBITOR |
| 3II5 | A:; B: | THE COMPLEX OF WILD-TYPE B-RAF WITH PYRAZOLO PYRIMIDINE INHIBITOR |
| 3IW4 | A:; B:; C: | CRYSTAL STRUCTURE OF PKC ALPHA IN COMPLEX WITH NVP-AEB071 |
| 3K54 | A: | STRUCTURES OF HUMAN BRUTON'S TYROSINE KINASE IN ACTIVE AND INACTIVE CONFORMATIONS SUGGESTS A MECHANISM OF ACTIVATION FOR TEC FAMILY KINASES. |
| 3K5U | A: | IDENTIFICATION, SAR STUDIES AND X-RAY COCRYSTAL ANALYSIS OF A NOVEL FURANO-PYRIMIDINE AURORA KINASE A INHIBITOR |
| 3KCF | A:; B:; C:; D:; E: | CRYSTAL STRUCTURE OF TGFBRI COMPLEXED WITH A PYRAZOLONE INHIBITOR |
| 3KF7 | A: | CRYSTAL STRUCTURE OF HUMAN P38ALPHA COMPLEXED WITH A TRIAZOLOPYRIMIDINE COMPOUND |
| 3KRJ | A: | CFMS TYROSINE KINASE IN COMPLEX WITH 4-CYANO-1H-IMIDAZOLE-2-CARBOXYLIC ACID (2-CYCLOHEX-1-ENYL-4-PIPERIDIN-4-YL-PHENYL)-AMIDE |
| 3KRL | A: | CFMS TYROSINE KINASE IN COMPLEX WITH 5-CYANO-FURAN-2-CARBOXYLIC ACID [4-(4-METHYL-PIPERAZIN-1-YL)-2-PIPERIDIN-1-YL-PHENYL]-AMIDE |
| 3KRW | A:186-549 | HUMAN GRK2 IN COMPLEX WITH GBETGAMMA SUBUNITS AND BALANOL (SOAK) |
| 3KRX | A:186-549 | HUMAN GRK2 IN COMPLEX WITH GBETGAMMA SUBUNITS AND BALANOL (CO-CRYSTAL) |
| 3KUL | A:; B: | KINASE DOMAIN OF HUMAN EPHRIN TYPE-A RECEPTOR 8 (EPHA8) |
| 3L8P | A: | CRYSTAL STRUCTURE OF CYTOPLASMIC KINASE DOMAIN OF TIE2 COMPLEXED WITH INHIBITOR CEP11207 |
| 3LAU | A: | CRYSTAL STRUCTURE OF AURORA2 KINASE IN COMPLEX WITH A GSK3BETA INHIBITOR |
| 3LCD | A: | INHIBITOR BOUND TO A DFG-IN STRUCTURE OF THE KINASE DOMAIN OF CSF-1R |
| 3M11 | A: | CRYSTAL STRUCTURE OF AURORA A KINASE COMPLEXED WITH INHIBITOR |
| 3MBL | A: | CRYSTAL STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK 1) IN COMPLEX WITH LIGAND AND MGADP |
| 3MDY | A:; C: | CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF THE BONE MORPHOGENETIC PROTEIN RECEPTOR TYPE-1B (BMPR1B) IN COMPLEX WITH FKBP12 AND LDN-193189 |
| 3MTF | A:; B: | CRYSTAL STRUCTURE OF THE ACVR1 KINASE IN COMPLEX WITH A 2-AMINOPYRIDINE INHIBITOR |
| 3MV5 | A: | CRYSTAL STRUCTURE OF AKT-1-INHIBITOR COMPLEXES |
| 3MVH | A: | CRYSTAL STRUCTURE OF AKT-1-INHIBITOR COMPLEXES |
| 3MVJ | A:; B:; E: | HUMAN CYCLIC AMP-DEPENDENT PROTEIN KINASE PKA INHIBITOR COMPLEX |
| 3MY0 | A:; B:; C:; D:; E:; F:; G:; H:; I:; J:; K:; L:; M:; N:; O:; P:; Q:; R:; S:; T:; U:; V:; W:; X: | CRYSTAL STRUCTURE OF THE ACVRL1 (ALK1) KINASE DOMAIN BOUND TO LDN-193189 |
| 3NAX | A: | PDK1 IN COMPLEX WITH INHIBITOR MP7 |
| 3NGA | A:; B: | HUMAN CK2 CATALYTIC DOMAIN IN COMPLEX WITH CX-4945 |
| 3NLB | A: | NOVEL KINASE PROFILE HIGHLIGHTS THE TEMPORAL BASIS OF CONTEXT DEPENDENT CHECKPOINT PATHWAYS TO CELL DEATH |
| 3NPC | A:; B: | CRYSTAL STRUCTURE OF JNK2 COMPLEXED WITH BIRB796 |
| 3NX8 | A: | HUMAN CAMP DEPENDENT PROTEIN KINASE IN COMPLEX WITH PHENOL |
| 3O2M | A:; B: | CRYSTAL STRUCTURE OF JNK1-ALPHA1 ISOFORM COMPLEX WITH A BIARYL TETRAZOL (A-82118) |
| 3OCB | A:; B: | AKT1 KINASE DOMAIN WITH PYRROLOPYRIMIDINE INHIBITOR |
| 3OCS | A: | CRYSTAL STRUCTURE OF BRUTON'S TYROSINE KINASE IN COMPLEX WITH INHIBITOR CGI1746 |
| 3OCT | A: | CRYSTAL STRUCTURE OF BRUTON'S TYROSINE KINASE MUTANT V555R IN COMPLEX WITH DASATINIB |
| 3OFM | A: | STRUCTURE OF A HUMAN CK2ALPHA PRIME, THE PARALOG ISOFORM OF THE CATALYTIC SUBUNIT OF PROTEIN KINASE CK2 FROM HOMO SAPIENS |
| 3OG7 | A:; B: | B-RAF KINASE V600E ONCOGENIC MUTANT IN COMPLEX WITH PLX4032 |
| 3OOG | A: | HUMAN CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH A SMALL FRAGMENT |
| 3OOM | A: | CRYSTAL STRUCTURE OF THE ACVR1 KINASE DOMAIN IN COMPLEX WITH THE IMIDAZO[1,2-B]PYRIDAZINE INHIBITOR K00507 |
| 3OW4 | A:; B: | DISCOVERY OF DIHYDROTHIENO- AND DIHYDROFUROPYRIMIDINES AS POTENT PAN AKT INHIBITORS |
| 3OXT | A: | HUMAN CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH AN INHIBITOR |
| 3P08 | A:; B: | CRYSTAL STRUCTURE OF THE HUMAN BTK KINASE DOMAIN |
| 3P9J | A: | AURORA A KINASE DOMAIN WITH PHTHALAZINONE PYRAZOLE INHIBITOR |
| 3PIX | A: | CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 2-ISOPROPYL-7-(4-METHYL-PIPERAZIN-1-YL)-4-(5-METHYL-2H-PYRAZOL-3-YLAMINO)-2H-PHTHALAZIN-1-ONE |
| 3PIY | A: | CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH R406 |
| 3PIZ | A: | CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH (5-AMINO-1-O-TOLYL-1H-PYRAZOL-4-YL)-[3-(1-METHANESULFONYL-PIPERIDIN-4-YL)-PHENYL]-METHANONE |
| 3PJ1 | A: | CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 3-(2,6-DICHLORO-PHENYL)-7-[4-(2-DIETHYLAMINO-ETHOXY)-PHENYLAMINO]-1-METHYL-3,4-DIHYDRO-1H-PYRIMIDO[4,5-D]PYRIMIDIN-2-ONE |
| 3PJ2 | A: | CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 2-[4-(2-DIETHYLAMINO-ETHOXY)-PHENYLAMINO]-6-(4-FLUORO-PHENOXY)-8-METHYL-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE |
| 3PJ3 | A: | CRYSTAL STRUCTURE OF BTK KINASE DOMAIN COMPLEXED WITH 2-METHYL-5-[(E)-(3-PHENYL-ACRYLOYL)AMINO]-N-(2-PHENYL-3H-IMIDAZO[4,5-B]PYRIDIN-6-YL)-BENZAMIDE |
| 3PLS | A: | RON IN COMPLEX WITH LIGAND AMP-PNP |
| 3POO | A: | HUMAN CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH AN INHIBITOR |
| 3PP0 | A:; B: | CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN HER2 (ERBB2). |
| 3PP1 | A: | CRYSTAL STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK 1) IN COMPLEX WITH LIGAND AND MGATP |
| 3PRF | A:; B: | CRYSTAL STRUCTURE OF HUMAN B-RAF KINASE DOMAIN IN COMPLEX WITH A NON-OXIME FUROPYRIDINE INHIBITOR |
| 3PXK | A:; B: | FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH PYRROLO[2,3-D]THIAZOLE |
| 3PYY | A:; B: | DISCOVERY AND CHARACTERIZATION OF A CELL-PERMEABLE, SMALL-MOLECULE C-ABL KINASE ACTIVATOR THAT BINDS TO THE MYRISTOYL BINDING SITE |
| 3PZE | A: | JNK1 IN COMPLEX WITH INHIBITOR |
| 3Q4U | A:; B:; C:; D: | CRYSTAL STRUCTURE OF THE ACVR1 KINASE DOMAIN IN COMPLEX WITH LDN-193189 |
| 3QKK | A: | SPIROCHROMANE AKT INHIBITORS |
| 3QKL | A: | SPIROCHROMANE AKT INHIBITORS |
| 3QKM | A: | SPIROCYCLIC SULFONAMIDES AS AKT INHIBITORS |
| 3QRI | A:; B: | THE CRYSTAL STRUCTURE OF HUMAN ABL1 KINASE DOMAIN IN COMPLEX WITH DCC-2036 |
| 3QRJ | A:; B: | THE CRYSTAL STRUCTURE OF HUMAN ABL1 KINASE DOMAIN T315I MUTANT IN COMPLEX WITH DCC-2036 |
| 3QRK | A: | THE CRYSTAL STRUCTURE OF HUMAN ABL1 KINASE DOMAIN IN COMPLEX WITH DP-987 |
| 3R1N | A: | MK3 KINASE BOUND TO COMPOUND 5B |
| 3R21 | A: | DESIGN, SYNTHESIS, AND BIOLOGICAL EVALUATION OF PYRAZOLOPYRIDINE-SULFONAMIDES AS POTENT MULTIPLE-MITOTIC KINASE (MMK) INHIBITORS (PART I) |
| 3RI1 | A:; B: | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF FGFR2 KINASE IN COMPLEX WITH ARQ 069 |
| 3ROC | A: | CRYSTAL STRUCTURE OF HUMAN P38 ALPHA COMPLEXED WITH A PYRIMIDINONE COMPOUND |
| 3SA0 | A: | COMPLEX OF ERK2 WITH NORATHYRIOL |
| 3SHE | A: | NOVEL ATP-COMPETITIVE MK2 INHIBITORS WITH POTENT BIOCHEMICAL AND CELL-BASED ACTIVITY THROUGHOUT THE SERIES |
| 3SLS | A:; B: | CRYSTAL STRUCTURE OF HUMAN MEK-1 KINASE IN COMPLEX WITH UCB1353770 AND AMPPNP |
| 3SXR | A:; B: | CRYSTAL STRUCTURE OF BMX NON-RECEPTOR TYROSINE KINASE COMPLEX WITH DASATINIB |
| 3SXS | A: | CRYSTAL STRUCTURE OF BMX NON-RECEPTOR TYROSINE KINASE COMPLEXED WITH PP2 |
| 3TXO | A: | PKC ETA KINASE IN COMPLEX WITH A NAPHTHYRIDINE |
| 3U6J | A: | CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH A PYRAZOLONE INHIBITOR |
| 3UE4 | A:; B: | STRUCTURAL AND SPECTROSCOPIC ANALYSIS OF THE KINASE INHIBITOR BOSUTINIB BINDING TO THE ABL TYROSINE KINASE DOMAIN |
| 3UYS | A:; B:; C:; D: | CRYSTAL STRUCTURE OF APO HUMAN CK1D |
| 3UYT | A:; B:; C:; D: | CRYSTAL STRUCTURE OF CK1D WITH PF670462 FROM P1 CRYSTAL FORM |
| 3UZP | A:; B: | CRYSTAL STRUCTURE OF CK1D WITH PF670462 FROM P21 CRYSTAL FORM |
| 3V5W | A:186-549 | HUMAN G PROTEIN-COUPLED RECEPTOR KINASE 2 IN COMPLEX WITH SOLUBLE GBETAGAMMA SUBUNITS AND PAROXETINE |
| 3V6R | A:; B: | DISCOVERY OF POTENT AND SELECTIVE COVALENT INHIBITORS OF JNK |
| 3V6S | A:; B: | DISCOVERY OF POTENT AND SELECTIVE COVALENT INHIBITORS OF JNK |
| 3VNT | A: | CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN VEGFR2 WITH A [1, 3]THIAZOLO[5,4-B]PYRIDINE DERIVATIVE |
| 3VO3 | A: | CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN VEGFR2 WITH IMIDAZO[1, 2-B]PYRIDAZINE DERIVATIVE |
| 3W55 | A: | THE STRUCTURE OF ERK2 IN COMPLEX WITH FR148083 |
| 3W8Q | A: | STRUCTURE OF THE HUMAN MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1 (MEK1) |
| 3ZBX | A: | X-RAY STRUCTURE OF C-MET KINASE IN COMPLEX WITH INHIBITOR 6-((6-(4-FLUOROPHENYL)-(1,2,4)TRIAZOLO(4,3-B)(1,2,4)TRIAZIN-3-YL)METHYL)QUINOLINE. |
| 3ZC5 | A: | X-RAY STRUCTURE OF C-MET KINASE IN COMPLEX WITH INHIBITOR ( S)-6-(1-(6-(1-METHYL-1H-PYRAZOL-4-YL)-(1,2,4)TRIAZOLO(4,3-B)PYRIDAZIN-3-YL)ETHYL)QUINOLINE. |
| 3ZCL | A: | X-RAY STRUCTURE OF C-MET KINASE IN COMPLEX WITH INHIBITOR ( S)-3-(1-(1H-PYRROLO(2,3-B)PYRIDIN-3-YL)ETHYL)-N-ISOPROPYL-( 1,2,4)TRIAZOLO(4,3-B)PYRIDAZIN-6-AMINE |
| 3ZLS | A: | CRYSTAL STRUCTURE OF MEK1 IN COMPLEX WITH FRAGMENT 6 |
| 3ZLW | A: | CRYSTAL STRUCTURE OF MEK1 IN COMPLEX WITH FRAGMENT 3 |
| 3ZLX | A: | CRYSTAL STRUCTURE OF MEK1 IN COMPLEX WITH FRAGMENT 18 |
| 3ZLY | A: | CRYSTAL STRUCTURE OF MEK1 IN COMPLEX WITH FRAGMENT 8 |
| 3ZM4 | A: | CRYSTAL STRUCTURE OF MEK1 IN COMPLEX WITH FRAGMENT 1 |
| 3ZS5 | A: | STRUCTURAL BASIS FOR KINASE SELECTIVITY OF THREE CLINICAL P38ALPHA INHIBITORS |
| 3ZSG | A: | X-RAY STRUCTURE OF P38ALPHA BOUND TO TAK-715 |
| 3ZSH | A: | X-RAY STRUCTURE OF P38ALPHA BOUND TO SCIO-469 |
| 3ZSI | A: | X-RAY STRUCTURE OF P38ALPHA BOUND TO VX-745 |
| 3ZXT | A:; B:; C:; D: | DIMERIC STRUCTURE OF DAPK-1 CATALYTIC DOMAIN IN COMPLEX WITH AMPPCP-MG |
| 3ZXZ | A: | X-RAY STRUCTURE OF PF-04217903 BOUND TO THE KINASE DOMAIN OF C-MET |
| 3ZYA | A: | HUMAN P38 MAP KINASE IN COMPLEX WITH 2-AMINO-PHENYLAMINO-DIBENZOSUBERONE |
| 3ZZE | A: | CRYSTAL STRUCTURE OF C-MET KINASE DOMAIN IN COMPLEX WITH N'-((3Z)-4-CHLORO-7-METHYL-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)-2-(4-HYDROXYPHENYL)PROPANOHYDRAZIDE |
| 4A4X | A: | NEK2-EDE BOUND TO CCT248662 |
| 4AA0 | A: | P38ALPHA MAP KINASE BOUND TO CMPD 2 |
| 4ACC | A:; B: | GSK3B IN COMPLEX WITH INHIBITOR |
| 4ACD | A:; B: | GSK3B IN COMPLEX WITH INHIBITOR |
| 4ACG | A:; B: | GSK3B IN COMPLEX WITH INHIBITOR |
| 4ACH | A:; B: | GSK3B IN COMPLEX WITH INHIBITOR |
| 4AE6 | A:; B: | STRUCTURE AND FUNCTION OF THE HUMAN SPERM-SPECIFIC ISOFORM OF PROTEIN KINASE A (PKA) CATALYTIC SUBUNIT CALPHA 2 |
| 4AE9 | A:; B: | STRUCTURE AND FUNCTION OF THE HUMAN SPERM-SPECIFIC ISOFORM OF PROTEIN KINASE A (PKA) CATALYTIC SUBUNIT C ALPHA 2 |
| 4AF3 | A: | HUMAN AURORA B KINASE IN COMPLEX WITH INCENP AND VX-680 |
| 4AFE | A: | NEK2 BOUND TO HYBRID COMPOUND 21 |
| 4AFJ | A:; B: | 5-ARYL-4-CARBOXAMIDE-1,3-OXAZOLES: POTENT AND SELECTIVE GSK-3 INHIBITORS |
| 4AG8 | A: | CRYSTAL STRUCTURE OF THE VEGFR2 KINASE DOMAIN IN COMPLEX WITH AXITINIB (AG-013736) (N-METHYL-2-(3-((E)-2-PYRIDIN-2-YL-VINYL)-1H- INDAZOL-6-YLSULFANYL)-BENZAMIDE) |
| 4AGC | A: | CRYSTAL STRUCTURE OF VEGFR2 (JUXTAMEMBRANE AND KINASE DOMAINS) IN COMPLEX WITH AXITINIB (AG-013736) (N-METHYL-2-( 3-((E)-2-PYRIDIN-2-YL-VINYL)-1H-INDAZOL-6-YLSULFANYL)-BENZAMIDE) |
| 4AGD | A: | CRYSTAL STRUCTURE OF VEGFR2 (JUXTAMEMBRANE AND KINASE DOMAINS) IN COMPLEX WITH SUNITINIB (SU11248) (N-2-DIETHYLAMINOETHYL)-5-((Z)-(5-FLUORO-2-OXO-1H-INDOL-3-YLIDENE)METHYL)-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE) |
| 4ALU | A: | BENZOFUROPYRIMIDINONE INHIBITORS OF PIM-1 |
| 4AOI | A: | CRYSTAL STRUCTURE OF C-MET KINASE DOMAIN IN COMPLEX WITH 4-( 3-((1H-PYRROLO(2,3-B)PYRIDIN-3-YL)METHYL)-(1,2,4)TRIAZOLO( 4,3-B)(1,2,4) TRIAZIN-6-YL)BENZONITRILE |
| 4AOT | A:; B: | CRYSTAL STRUCTURE OF HUMAN SERINE THREONINE KINASE-10 (LOK) BOUND TO GW830263A |
| 4AP7 | A: | CRYSTAL STRUCTURE OF C-MET KINASE DOMAIN IN COMPLEX WITH 4-( (6-(4-FLUOROPHENYL)-(1,2,4)TRIAZOLO(4,3-B)(1,2,4)TRIAZIN-3-YL)METHYL) PHENOL |
| 4ARK | A: | CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MAP KINASE KINASE 1 (MEK1) IN COMPLEX WITH A SMALL MOLECULE INHIBITOR AND ADP |
| 4AS0 | A: | CYCLOMETALATED PHTHALIMIDES AS PROTEIN KINASE INHIBITORS |
| 4ASD | A: | CRYSTAL STRUCTURE OF VEGFR2 (JUXTAMEMBRANE AND KINASE DOMAINS) IN COMPLEX WITH SORAFENIB (BAY 43-9006) |
| 4ASE | A: | CRYSTAL STRUCTURE OF VEGFR2 (JUXTAMEMBRANE AND KINASE DOMAINS) IN COMPLEX WITH TIVOZANIB (AV-951) |
| 4AU8 | A:; B: | CRYSTAL STRUCTURE OF COMPOUND 4A IN COMPLEX WITH CDK5, SHOWING AN UNUSUAL BINDING MODE TO THE HINGE REGION VIA A WATER MOLECULE |
| 4AWI | A: | HUMAN JNK1ALPHA KINASE WITH 4-PHENYL-7-AZAINDOLE IKK2 INHIBITOR. |
| 4B0G | A: | COMPLEX OF AURORA-A BOUND TO AN IMIDAZOPYRIDINE-BASED INHIBITOR |
| 4B4L | A: | CRYSTAL STRUCTURE OF AN ARD DAP-KINASE 1 MUTANT |
| 4BC6 | A: | CRYSTAL STRUCTURE OF HUMAN SERINE THREONINE KINASE-10 BOUND TO NOVEL BOSUTINIB ISOFORM 1, PREVIOUSLY THOUGHT TO BE BOSUTINIB |
| 4BCF | A: | STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2-AMINO-4-HETEROARYL-PYRIMIDINE INHIBITOR |
| 4BCG | A: | STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2-AMINO-4-HETEROARYL-PYRIMIDINE INHIBITOR |
| 4BCH | A: | STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2-AMINO-4-HETEROARYL-PYRIMIDINE INHIBITOR |
| 4BCI | A: | STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2-AMINO-4-HETEROARYL-PYRIMIDINE INHIBITOR |
| 4BCJ | A: | STRUCTURE OF CDK9 IN COMPLEX WITH CYCLIN T AND A 2-AMINO-4-HETEROARYL-PYRIMIDINE INHIBITOR |
| 4BGG | A:; B:; C:; D: | CRYSTAL STRUCTURE OF THE ACVR1 KINASE IN COMPLEX WITH LDN-213844 |
| 4BYI | A: | AURORA A KINASE BOUND TO A HIGHLY SELECTIVE IMIDAZOPYRIDINE INHIBITOR |
| 4BYJ | A: | AURORA A KINASE BOUND TO A HIGHLY SELECTIVE IMIDAZOPYRIDINE INHIBITOR |
| 4BZN | A: | CRYSTAL STRUCTURE OF PIM1 IN COMPLEX WITH A PYRROLO(1,2-A) PYRAZINONE INHIBITOR |
| 4BZO | A: | CRYSTAL STRUCTURE OF PIM1 IN COMPLEX WITH A PYRROLO-PYRAZINONE INHIBITOR |
| 4C02 | A: | CRYSTAL STRUCTURE OF HUMAN ACVR1 (ALK2) IN COMPLEX WITH FKBP12.6 AND DORSOMORPHIN |
| 4DBN | A:; B: | CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN B-RAF WITH A [1, 3]THIAZOLO[5,4-B]PYRIDINE DERIVATIVE |
| 4DEA | A: | AURORA A IN COMPLEX WITH YL1-038-18 |
| 4DHF | A:; B: | STRUCTURE OF AURORA A MUTANT BOUND TO BIOGENIDEC CPD 15 |
| 4DYM | A: | CRYSTAL STRUCTURE OF THE ACVR1 KINASE DOMAIN IN COMPLEX WITH THE IMIDAZO[1,2-B]PYRIDAZINE INHIBITOR K00135 |
| 4E26 | A:; B: | BRAF IN COMPLEX WITH AN ORGANIC INHIBITOR 7898734 |
| 4EKL | A: | AKT1 WITH GDC0068 |
| 4EQU | A:; B: | HUMAN STK-10 (LOK) KINASE DOMAIN IN DFG-OUT CONFORMATION WITH INHIBITOR DSA-7 |
| 4EXU | | [entry was replaced by entry 4YNO without any SCOP domain information] |
| 4EYJ | A: | MAPK13 COMPLEX WITH INHIBITOR |
| 4EYM | A: | MAPK13 COMPLEX WITH INHIBITOR |
| 4EZ5 | A: | CDK6 (MONOMERIC) IN COMPLEX WITH INHIBITOR |
| 4FC0 | A:; B: | CRYSTAL STRUCTURE OF HUMAN KINASE DOMAIN OF B-RAF WITH A DFG-OUT INHIBITOR |
| 4FG7 | A: | CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE I 1-293 IN COMPLEX WITH ATP |
| 4FG8 | A:; B: | CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE I 1-315 IN COMPLEX WITH ATP |
| 4FG9 | A:; B: | CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE I 1-320 IN COMPLEX WITH ATP |
| 4FGB | A: | CRYSTAL STRUCTURE OF HUMAN CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE I APO FORM |
| 4FUX | A: | CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH E75 |
| 4FUY | A: | CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK2 |
| 4FV0 | A: | CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK3 |
| 4FV1 | A: | CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK4 |
| 4FV2 | A: | CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK5 |
| 4FV3 | A: | CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK6 |
| 4FV4 | A: | CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK7 |
| 4FV5 | A: | CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH EK9 |
| 4FV6 | A: | CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH E57 |
| 4FV7 | A: | CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH E94 |
| 4FV8 | A: | CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH E63 |
| 4FV9 | A: | CRYSTAL STRUCTURE OF THE ERK2 COMPLEXED WITH E71 |
| 4G16 | A: | CRYSTAL STRUCTURE OF CK1G3 WITH 2-[(4-{[3-(TRIFLUOROMETHYL)PYRIDIN2-YL]OXY}PHENYL)AMINO]-1H-BENZIMIDAZOLE-6-CARBONITRILE |
| 4G17 | A: | CRYSTAL STRUCTURE OF CK1G3 WITH 2-[(4-TERT-BUTYLPHENYL)AMINO]-1H-BENZIMIDAZOLE-6-CARBONITRILE |
| 4G5J | A: | CRYSTAL STRUCTURE OF EGFR KINASE IN COMPLEX WITH BIBW2992 |
| 4G5P | A:; B: | CRYSTAL STRUCTURE OF EGFR KINASE T790M IN COMPLEX WITH BIBW2992 |
| 4G6N | A: | CRYSTAL STRUCTURE OF THE ERK2 |
| 4G6O | A: | CRYSTAL STRUCTURE OF THE ERK2 |
| 4GG5 | A: | CRYSTAL STRUCTURE OF CMET IN COMPLEX WITH NOVEL INHIBITOR |
| 4GG7 | A: | CRYSTAL STRUCTURE OF CMET IN COMPLEX WITH NOVEL INHIBITOR |
| 4GV1 | A: | PKB ALPHA IN COMPLEX WITH AZD5363 |
| 4H1J | A: | CRYSTAL STRUCTURE OF PYK2 WITH THE PYRAZOLE 13A |
| 4H1M | A: | CRYSTAL STRUCTURE OF PYK2 WITH THE INDOLE 10C |
| 4H58 | A:; B:; C: | BRAF IN COMPLEX WITH COMPOUND 3 |
| 4HGL | A: | CRYSTAL STRUCTURE OF CK1G3 WITH COMPOUND 1 |
| 4HGS | A: | CRYSTAL STRUCTURE OF CK1GS WITH COMPOUND 13 |
| 4HNI | A:; B: | CRYSTAL STRUCTURE OF CK1E IN COMPLEX WITH PF4800567 |
| 4HOK | A:; C:; E:; G:; I:; K:; M:; O:; Q:; S:; U:; W: | CRYSTAL STRUCTURE OF APO CK1E |
| 4HVS | A: | CRYSTAL STRUCTURE OF KIT KINASE DOMAIN WITH A SMALL MOLECULE INHIBITOR, PLX647 |
| 4HW7 | A: | CRYSTAL STRUCTURE OF FMS KINASE DOMAIN WITH A SMALL MOLECULAR INHIBITOR, PLX647-OME |
| 4I41 | A: | CRYSTAL STRUCTURE OF HUMAN SER/THR KINASE PIM1 IN COMPLEX WITH MITOXANTRONE |
| 4IMY | A:; C:; E: | THE AFF4 SCAFFOLD BINDS HUMAN P-TEFB ADJACENT TO HIV TAT |
| 4IZ5 | A:; B:; C:; D: | STRUCTURE OF THE COMPLEX BETWEEN ERK2 PHOSPHOMIMETIC MUTANT AND PEA-15 |
| 4IZ7 | A:; C: | STRUCTURE OF NON-PHOSPHORYLATED ERK2 BOUND TO THE PEA-15 DEATH EFFECTOR DOMAIN |
| 4IZA | A:; C: | STRUCTURE OF DUALLY PHOSPHORYLATED ERK2 BOUND TO THE PEA-15 DEATH EFFECTOR DOMAIN |
| 4K33 | A: | CRYSTAL STRUCTURE OF FGF RECEPTOR 3 (FGFR3) KINASE DOMAIN HARBORING THE K650E MUTATION, A GAIN-OF-FUNCTION MUTATION RESPONSIBLE FOR THANATOPHORIC DYSPLASIA TYPE II AND SPERMATOCYTIC SEMINOMA |
| 4KSP | A:; B: | CRYSTAL STRUCTURE OF HUMAN B-RAF BOUND TO A DFG-OUT INHIBITOR TAK-632 |
| 4L7F | A: | CO-CRYSTAL STRUCTURE OF JNK1 AND AX13587 |
| 4NM5 | A: | CRYSTAL STRUCTURE OF GSK-3/AXIN COMPLEX BOUND TO PHOSPHORYLATED WNT RECEPTOR LRP6 C-MOTIF |
| 4NWM | A:; B: | CRYSTAL STRUCTURE OF BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE COMPLEXED WITH BMS-809959 AKA 4-TERT-BUTYL-N-[2-ME THYL-3-(6-{[4-(MORPHOLINE-4-CARBONYL)PHENYL]AMINO}-9H- PURIN-2-YL)PHENYL]BENZAMIDE |
)
)